AmericanHHM

Press Releases

Information on the most recent studies in health and medical sciences is provided by American Hospital and Healthcare Management, with a focus on healthcare and preventive medicine in particular. In addition, it offers the most advanced health care techniques and considerable improvements in hospital administration.

Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics

Wednesday, August 31, 2022

Guardant Health Inc a leading precision oncology company today announced an expanded collaboration with Merck KGaA Darmstadt Germany a leading science and technology company operating its biopharmaceuticals business in the US and Canada as EMD Serono...

Healthmine and Decision Point Forge Partnership to Evolve Health Plans to Member Experience-Centric Organizations

Wednesday, August 31, 2022

Healthmine a leader in technologyenabled member engagement and reward solutions for health plans and Decision Point the leading member engagement predictive analytics company have announced a strategic partnership Decision Points unique data driven t...

Hackensack University Medical Center Becomes First in North Jersey to Offer Aquablation® Therapy to Treat Enlarged Prostates

Monday, August 29, 2022

Urologists at Hackensack University Medical Center have become the first in northern New Jersey to offer an innovative treatment for benign prostatic hyperplasia BPH that uses a highintensity waterjet to destroy ablate excess prostate tissue that cau...

Genome Insight and Ajou University Medical Center Launch Program to Apply Whole Genome Sequencing for Routine Cancer Care

Monday, August 29, 2022

Genome Insight a cancer whole genome platform company is launching a pilot program in Ajou University Medical Center to test the use of Whole Genome Sequencing WGS in routine cancer care setting Cancer patients at various stages in the treatment jour...

Invictus Completes Important Milestone Towards Commercialization With FDA Submission For NICU Active Noise Control Device

Thursday, August 25, 2022

Invictus Medical has submitted a De Novo application to the FDA for its Neoasis incubatorbased active noise control device FDA clearance is an essential step in the commercialization process of all medical devices and this type of application is used...

Managed Health and ADP Team up to Bring Companies a Unique Health Care Solution

Thursday, August 25, 2022

Managed Health and ADP a human resources management and software provider announced a partnership to offer companies the Managed Health Champ Plan as a new unique innovative healthcare solution Managed Health designed this program as an independent b...

Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation

Wednesday, August 24, 2022

Tenon Medical Inc a medical device company that has developed a proprietary US Food and Drug Administration FDA cleared surgical implant system for sacroiliac joint SI Joint fixationfusion surgery today announced its virtual participation in the foll...

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

Wednesday, August 24, 2022

RxSight Inc an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery today announced plans to participate in the upcoming Wells Fargo Healthcare Conference RxSights management is scheduled to parti...

Centene Signs Definitive Agreement To Divest Its Spanish And Central European Businesses

Tuesday, August 23, 2022

Centene Corporation announced today that as part of its previously announced review of strategic alternatives for its international portfolio it has signed a definitive agreement to sell to Vivalto Sant its Spanish and Central European businesses whi...

Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review

Tuesday, August 23, 2022

Jaguar Health announced that its Orphan Drug Designation ODD application for crofelemer submitted to the US Food and Drug Administration for a rare congenital diarrheal disorder called microvillus inclusion disease MVID has been accepted by the FDA f...